REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmesis International Ltd. (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmesis International Ltd. Profile Updated: August 02, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Pharmesis International Ltd. operates as a pharmaceutical company specializing in R & D, production and sale of Western medicine and TCM formulated products for the treatment of illnesses relating to liver and gall bladder diseases. The company distributes its products to hospitals under “Kinna” and “Longlife” brand names. Pharmesis International Ltd. operates production facilities located in Chengdu and Gulin in China. The company was incorporated in 2003.

Legal Address
No. 8 Yingbin Road,Chengdu
Chengdu; Sichuan;

Contact Details: Purchase the Pharmesis International Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmesis International Ltd. report to view the information.
Outstanding Shares:
Purchase the Pharmesis International Ltd. report to view the information.
Financial Auditors:
Purchase the Pharmesis International Ltd. report to view the information.
Incorporation Date:
2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
22.76%
Purchase this report to view the information.
20.74%
Purchase this report to view the information.
13.04%
Purchase this report to view the information.
9.92%
Company Performance
Financial values in the chart are available after Pharmesis International Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-42.17%
Total operating revenue
-45.4%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-26.83%
Total equity
-35.32%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
9.75%
Quick Ratio
-1.32%
Cash Ratio
-0.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?